Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.

Gao J, Lan J, Liao H, Yang F, Qiu P, Jin F, Wang S, Shen L, Chao T, Zhang C, Zhu Y

Open source

DOI
10.1186/s12885-023-11434-9
Published
2023 Dec 7
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-023-11434-9,
  title = {Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.},
  author = {Gao J and Lan J and Liao H and Yang F and Qiu P and Jin F and Wang S and Shen L and Chao T and Zhang C and Zhu Y},
  year = {2023},
  journal = {BMC cancer},
  doi = {10.1186/s12885-023-11434-9},
  url = {https://doi.org/10.1186/s12885-023-11434-9}
}

RIS

TY  - JOUR
TI  - Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
AU  - Gao J
AU  - Lan J
AU  - Liao H
AU  - Yang F
AU  - Qiu P
AU  - Jin F
AU  - Wang S
AU  - Shen L
AU  - Chao T
AU  - Zhang C
AU  - Zhu Y
PY  - 2023
JO  - BMC cancer
DO  - 10.1186/s12885-023-11434-9
UR  - https://doi.org/10.1186/s12885-023-11434-9
ER  - 

APA

J, G., J, L., H, L., F, Y., P, Q., F, J., S, W., L, S., T, C., C, Z., & Y, Z. (2023). Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.. BMC cancer. https://doi.org/10.1186/s12885-023-11434-9

Source records